Zebra Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-12,707
| Closed | -$122K | – | 70 |
|
2022
Q3 | $122K | Buy |
12,707
+137
| +1% | +$1.32K | 0.46% | 66 |
|
2022
Q2 | $91K | Sell |
12,570
-369
| -3% | -$2.67K | 0.27% | 90 |
|
2022
Q1 | $167K | Sell |
12,939
-3,807
| -23% | -$49.1K | 0.38% | 100 |
|
2021
Q4 | $267K | Sell |
16,746
-6,172
| -27% | -$98.4K | 0.43% | 85 |
|
2021
Q3 | $368K | Buy |
+22,918
| New | +$368K | 0.45% | 81 |
|